Buchholz, S., Morrow, A.F., and Coleman, P.L. (2008) Atypical antipsychotic-induced diabetes mellitus: an update on epidemiology and postulated mechanisms. Internal Medicine Journal, 38 (7). pp. 602-606.

PDF (Published Version) - Published Version Restricted to Repository staff only

 

43

4

Abstract

Diabetic ketoacidosis and hyperglycaemic hyperosmolar syndrome are rare, but potentially fatal complications of antipsychotic-associated hyperglycaemia. The mechanisms for this remain unclear, but are probably multifactorial. The suggested reasons include drug-induced weight gain and adiposity, development of the metabolic syndrome, antagonism of serotonin (5-hydroxytryptamine) receptors, drug-induced leptin resistance, dyslipidaemia mediated pancreatic β-cell damage and hepatocyte transcription factor dysregulation. Patients with schizophrenia are known to be at a higher genetic risk of developing diabetes mellitus and cardiovascular disease. This review emphasizes a rare case of hyperosmolar hyperglycaemic syndrome in a young man with schizophrenia and discusses proposed mechanisms for the development of antipsychotic-associated diabetes mellitus.

Actions (Repository Staff Only)

Item Control Page